After two decades effecting change in commercial diagnostics, this achievement is the brightest spot of my career, with a profound culmination of scientific, clinical, and social impact," —Elizabeth ...

FOSTER CITY, Calif., May 28, 2025 /PRNewswire/ -- 1Cell.Ai, a precision oncology company developing advanced cell and molecular profiling platforms, announced the successful completion of a CLIA-grade ...

Company sees a significant market opportunity for reference lab agreements to identify which variant is responsible for positive COVID-19 test results Validation paves the way for launch of variant ...

While many advocate that oversight of AI analyses of lab data be handled through CLIA, some stakeholders say that FDA should play a role.